Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 55

Sort by

Sort Order Select

Journal Articles

Combined Effect of Unrelated Donor Age and HLA Peptide-Binding Motifs (PBM) Match Status on HCT Outcomes

Rohtesh S. Mehta, Effie W. Petersdorf, Stephen R. Spellman, Stephanie J. Lee

Blood (2023) 142 (Supplement 1): 1045.

https://doi.org/10.1182/blood-2023-173887

Published: 2023

Journal Articles

HLA-DQ heterodimers in hematopoietic cell transplantation

Effie W. Petersdorf, Mats Bengtsson, Mary Horowitz, Caroline McKallor, Stephen R. Spellman, Eric Spierings, Ted A. Gooley, Phil Stevenson, on behalf of the International Histocompatibility Working Group in Hematopoietic Cell Transplantation

Blood (2022) 139 (20): 3009–3017.

https://doi.org/10.1182/blood.2022015860

Published: 2022

Includes: Supplemental data

Journal Articles

HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide

Blood (2022) 139 (10): 1452–1468.

https://doi.org/10.1182/blood.2021013443

Published: 2022

Includes: Supplemental data

Journal Articles

What Do Patients Think about Palliative Care? a National Survey of Hematopoietic Stem Cell Transplant Recipients

Areej El-Jawahri, Christa Meyer, Lih-Wen Mau, Deborah Mattila, Linda J Burns, Christina Ullrich, Hemant S. Murthy, William A. Wood, Effie W. Petersdorf, Thomas W. LeBlanc

Blood (2021) 138 (Supplement 1): 2968.

https://doi.org/10.1182/blood-2021-149766

Published: 2021

Journal Articles

Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen–mismatched donors

Brian Kornblit, Barry E. Storer, Niels S. Andersen, Michael B. Maris, Thomas R. Chauncey, Effie W. Petersdorf, Ann E. Woolfrey, Mary E. D. Flowers, Rainer Storb, David G. Maloney, Brenda M. Sandmaier

Blood (2020) 136 (13): 1499–1506.

https://doi.org/10.1182/blood.2020005338

Published: 2020

Includes: Supplemental data

Journal Articles

HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation

Effie W. Petersdorf, Philip Stevenson, Mats Bengtsson, Dianne De Santis, Valerie Dubois, Ted Gooley, Mary Horowitz, Katharine Hsu, J. Alejandro Madrigal, Mari Malkki, Caroline McKallor, Yasuo Morishima, Machteld Oudshoorn, Stephen R. Spellman, Jean Villard, Mary Carrington

Blood (2020) 136 (3): 362–369.

https://doi.org/10.1182/blood.2020005743

Published: 2020

Includes: Supplemental data

Journal Articles

Sirolimus Combined with Cyclosporine (CSP) and Mycophenolate Mofetil (MMF) As Graft-Vs-Host Disease (GVHD) Prophylaxis after Nonmyeloablative (NMA) Hematopoietic Cell Transplantation (HCT) Using HLA Class I or Class II Antigen Mismatched Donors: Results from a Phase II Multi-Center Trial

Brian Kornblit, MD PhD, Barry Storer, Michael B. Maris, MD, Niels Smedegaard Andersen, MD PhD, Thomas R. Chauncey, MD PhD, Effie W. Petersdorf, MD, Ann Woolfrey, MD, David G. Maloney, MD PhD, Rainer Storb, MD, Brenda M Sandmaier, MD

Blood (2019) 134 (Supplement_1): 369.

https://doi.org/10.1182/blood-2019-123196

Published: 2019

Journal Articles

Analysis of 10,462 8/8 HLA- Matched Unrelated Donor Transplants Could Not Identify a Donor Selection Score, As Younger Age Is the Only Significant Donor Characteristic Associated with Survival

Blood (2017) 130 (Supplement 1): 848.

https://doi.org/10.1182/blood.V130.Suppl_1.848.848

Published: 2017

Journal Articles

HLA mismatching in transplantation

Effie W. Petersdorf

Blood (2015) 125 (7): 1058–1059.

https://doi.org/10.1182/blood-2014-12-619015

Published: 2015

Journal Articles

HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation

Blood (2014) 124 (26): 3996–4003.

https://doi.org/10.1182/blood-2014-09-599969

Published: 2014

Includes: Supplemental data

Journal Articles

Minimal Residual Disease Does Not Impact Risk of Relapse in Myeloablative Umbilical Cord Blood Transplant Recipients: Comparison with Matched and Mismatched Unrelated Transplants

Filippo Milano, MD PhD, Ted A. Gooley, PhD, Brent L. Wood, MD PhD, Ann E Woolfrey, MD, Effie W. Petersdorf, MD, Frederick R. Appelbaum, MD, Colleen Delaney, MD MSC

Blood (2014) 124 (21): 2579.

https://doi.org/10.1182/blood.V124.21.2579.2579

Published: 2014

Journal Articles

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation

Blood (2014) 124 (16): 2596–2606.

https://doi.org/10.1182/blood-2014-05-576041

Published: 2014

Journal Articles

Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation

Blood (2014) 123 (8): 1270–1278.

https://doi.org/10.1182/blood-2013-10-532671

Published: 2014

Includes: Supplemental data

Journal Articles

The CIBMTR Chronic GVHD Risk Group Predicts Major Outcomes In An Independent Validation Cohort

Blood (2013) 122 (21): 706.

https://doi.org/10.1182/blood.V122.21.706.706

Published: 2013

Journal Articles

The major histocompatibility complex: a model for understanding graft-versus-host disease

Effie W. Petersdorf

Blood (2013) 122 (11): 1863–1872.

https://doi.org/10.1182/blood-2013-05-355982

Published: 2013

Journal Articles

Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease

Yoshihiro Inamoto, Barry E. Storer, Effie W. Petersdorf, J. Lee Nelson, Stephanie J. Lee, Paul A. Carpenter, Brenda M. Sandmaier, John A. Hansen, Paul J. Martin, Mary E. D. Flowers

Blood (2013) 121 (25): 5098–5103.

https://doi.org/10.1182/blood-2012-10-464198

Published: 2013

Journal Articles

Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation

Marcelo A. Fernández-Viña, John P. Klein, Michael Haagenson, Stephen R. Spellman, Claudio Anasetti, Harriet Noreen, Lee Ann Baxter-Lowe, Pedro Cano, Neal Flomenberg, Dennis L. Confer, Mary M. Horowitz, Machteld Oudshoorn, Effie W. Petersdorf, Michelle Setterholm, Richard Champlin, Stephanie J. Lee, Marcos de Lima

Blood (2013) 121 (22): 4603–4610.

https://doi.org/10.1182/blood-2013-02-481945

Published: 2013

Includes: Supplemental data

Journal Articles

Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation

Effie W. Petersdorf, Mari Malkki, Mary M. Horowitz, Stephen R. Spellman, Michael D. Haagenson, Tao Wang

Blood (2013) 121 (10): 1896–1905.

https://doi.org/10.1182/blood-2012-11-465161

Published: 2013

Includes: Supplemental data

Journal Articles

Donor KIR3DL1 and HLA-B Allotypes Control Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

Fabio Giglio, MD, Ted A. Gooley, PhD, Jeffrey M Venstrom, MD, Meighan M Gallagher, LiHua Hou, PhD, Carolyn K Hurley, PhD, Tatiana Lebedeva, MD, PhD, Harriet Noreen, CHS, Raja Rajalingam, PhD, Elaine F Reed, PhD, Neng Yu, MD, Cynthia Vierra-Green, MS, Michael D Haagenson, MS, Mari Malkki, PhD, Effie W. Petersdorf, MD, Stephen Spellman, MBS, Katharine C. Hsu, MD, PhD

Blood (2012) 120 (21): 349.

https://doi.org/10.1182/blood.V120.21.349.349

Published: 2012

Journal Articles

Genetics of Graft-Versus-Host Disease

Effie W. Petersdorf, MD

Blood (2011) 118 (21): SCI-49.

https://doi.org/10.1182/blood.V118.21.SCI-49.SCI-49

Published: 2011

NARROW

Combined Effect of Unrelated Donor Age and HLA Peptide-Binding Motifs (PBM) Match Status on HCT Outcomes

HLA-DQ heterodimers in hematopoietic cell transplantation

HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide

What Do Patients Think about Palliative Care? a National Survey of Hematopoietic Stem Cell Transplant Recipients

Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen–mismatched donors

HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation

Sirolimus Combined with Cyclosporine (CSP) and Mycophenolate Mofetil (MMF) As Graft-Vs-Host Disease (GVHD) Prophylaxis after Nonmyeloablative (NMA) Hematopoietic Cell Transplantation (HCT) Using HLA Class I or Class II Antigen Mismatched Donors: Results from a Phase II Multi-Center Trial

Analysis of 10,462 8/8 HLA- Matched Unrelated Donor Transplants Could Not Identify a Donor Selection Score, As Younger Age Is the Only Significant Donor Characteristic Associated with Survival

HLA mismatching in transplantation

HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation

Minimal Residual Disease Does Not Impact Risk of Relapse in Myeloablative Umbilical Cord Blood Transplant Recipients: Comparison with Matched and Mismatched Unrelated Transplants

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation

Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation

The CIBMTR Chronic GVHD Risk Group Predicts Major Outcomes In An Independent Validation Cohort

The major histocompatibility complex: a model for understanding graft-versus-host disease

Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease

Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation

Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation

Donor KIR3DL1 and HLA-B Allotypes Control Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

Genetics of Graft-Versus-Host Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only